209 related articles for article (PubMed ID: 25916549)
1. In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.
Ni C; Chen Y; Zeng M; Pei R; Du Y; Tang L; Wang M; Hu Y; Zhu H; He M; Wei X; Wang S; Ning X; Wang M; Wang J; Ma L; Chen X; Sun Q; Tang H; Wang Y; Wang X
Cell Res; 2015 Jul; 25(7):785-800. PubMed ID: 25916549
[TBL] [Abstract][Full Text] [Related]
2. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
3. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.
Wang HB; Zhang H; Zhang JP; Li Y; Zhao B; Feng GK; Du Y; Xiong D; Zhong Q; Liu WL; Du H; Li MZ; Huang WL; Tsao SW; Hutt-Fletcher L; Zeng YX; Kieff E; Zeng MS
Nat Commun; 2015 Feb; 6():6240. PubMed ID: 25670642
[TBL] [Abstract][Full Text] [Related]
5. A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.
Ziegler P; Tian Y; Bai Y; Abrahamsson S; Bäckerholm A; Reznik AS; Green A; Moore JA; Lee SE; Myerburg MM; Park HJ; Tang KW; Shair KHY
PLoS Pathog; 2021 Apr; 17(4):e1009041. PubMed ID: 33914843
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
7. Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study.
Yip YL; Pang PS; Deng W; Tsang CM; Zeng M; Hau PM; Man C; Jin Y; Yuen AP; Tsao SW
PLoS One; 2013; 8(10):e78395. PubMed ID: 24167620
[TBL] [Abstract][Full Text] [Related]
8. A cancer-associated Epstein-Barr virus variant with epithelial tropism.
Frappier L
Trends Microbiol; 2013 Dec; 21(12):616-7. PubMed ID: 24183509
[TBL] [Abstract][Full Text] [Related]
9. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
10. [The entry of Epstein-Barr virus into B lymphocytes and epithelial cells during infection].
Zuo LL; Zhu MJ; Du SJ; Lu JH; Li GY
Bing Du Xue Bao; 2014 Jul; 30(4):476-82. PubMed ID: 25272606
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
Rac J; Haas F; Schumacher A; Middeldorp JM; Delecluse HJ; Speck RF; Bernasconi M; Nadal D
PLoS One; 2015; 10(4):e0123645. PubMed ID: 25856387
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.
Port RJ; Pinheiro-Maia S; Hu C; Arrand JR; Wei W; Young LS; Dawson CW
J Pathol; 2013 Nov; 231(3):367-77. PubMed ID: 23934731
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
15. Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission.
Nanbo A; Terada H; Kachi K; Takada K; Matsuda T
J Virol; 2012 Sep; 86(17):9285-96. PubMed ID: 22718812
[TBL] [Abstract][Full Text] [Related]
16. In-cell infection: bringing uninvited guests.
Lee Y; Overholtzer M
Cell Res; 2015 Jun; 25(6):647-8. PubMed ID: 25952669
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
Liu S; Li H; Chen L; Yang L; Li L; Tao Y; Li W; Li Z; Liu H; Tang M; Bode AM; Dong Z; Cao Y
Carcinogenesis; 2013 Mar; 34(3):627-37. PubMed ID: 23180656
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and nasopharyngeal carcinoma.
Young LS; Dawson CW
Chin J Cancer; 2014 Dec; 33(12):581-90. PubMed ID: 25418193
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal malignant epithelial cell, lymphocyte and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: immunohistochemical data and EBV DNA tissue indices.
Groma V; Kazanceva A; Nora-Krukle Z; Murovska M
Pathol Res Pract; 2012 Sep; 208(9):518-26. PubMed ID: 22770970
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW
Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]